Compare CNTX & VIDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNTX | VIDA |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.2M | 64.7M |
| IPO Year | 2021 | 2026 |
| Metric | CNTX | VIDA |
|---|---|---|
| Price | $0.48 | $2.44 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $6.60 | N/A |
| AVG Volume (30 Days) | ★ 2.2M | 98.2K |
| Earning Date | 05-08-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.39 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.49 | $2.06 |
| 52 Week High | $3.62 | $4.25 |
| Indicator | CNTX | VIDA |
|---|---|---|
| Relative Strength Index (RSI) | 32.19 | 35.83 |
| Support Level | N/A | $2.17 |
| Resistance Level | $0.68 | $2.88 |
| Average True Range (ATR) | 0.05 | 0.33 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 8.78 | 13.97 |
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.